WOCKPHARMA Wockhardt Ltd Expansion Plans Announcement 2024 - Successful Liver Transplant Wockhardt's antibiotic Zaynich (Zidebactam/Cefepime) successfully allowed a US cancer patient to undergo a liver transplant after it eradicated severe drug-resistant infections. This marks another instance where 45 patients have benefited from this treatment under compassionate use..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Wockhardt Ltd